SEC Info - Sherman Steven - ‘4’ for 5/24/23 re: Ekso Bionics Holdings, Inc.

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

SHERMAN STEVEN

2. Issuer Name and Ticker or Trading Symbol
EKSO BIONICS HOLDINGS, INC. [EKSO]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director

_____ 10% Owner

__X__ Officer (give title below)

_____ Other (specify below)

Executive Chair

(Last)

(First)

(Middle)

C/O EKSO BIONICS HOLDINGS, INC., 101 GLACIER POINT, SUITE A

3. Date of Earliest Transaction (Month/Day/Year)
5/24/23

(Street)

SAN RAFAEL, CA 94901

4. If Amendment, Date Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Rule 10b5-1(c) Transaction Indication
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security
(Instr. 3)

2. Transaction Date (Month/Day/Year)

2A. Deemed Execution Date, if any (Month/Day/Year)

3. Transaction Code
(Instr. 8)

4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)

5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)

6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)

7. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

Amount

(A) or (D)

Price

Common Stock

5/24/23

45,660 ⁽¹⁾

$1.4427 ⁽²⁾

364,913

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address

Relationships

Director

10% Owner

Officer

Other

SHERMAN STEVEN
C/O EKSO BIONICS HOLDINGS, INC.
101 GLACIER POINT, SUITE A
SAN RAFAEL, CA 94901

Executive Chair

Signatures

/s/ Jerome Wong, as Attorney-in-Fact

5/26/23

^**Signature of Reporting Person

Date

Explanation of Responses:

If the form is filed by more than one reporting person, see Instruction 4(b)(v).

Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

(1)

Represents shares sold by the Reporting Person on May 24, 2023 to cover tax withholding obligations incurred upon the vesting and settlement of the restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on December 7, 2022.

(2)

These shares were sold in a single transaction at a price of $1.4427 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

____________ Transaction Code:
S	Open market or private sale of non-derivative or derivative security.

Sherman Steven – ‘4’ for 5/24/23 re: Ekso Bionics Holdings, Inc.

On: Friday, 5/26/23, at 6:45pm ET · For: 5/24/23 · As: Officer · Accession #: 1549084-23-35 · File #: 1-37854

Previous ‘4’: ‘4/A’ on 5/17/23 for 3/8/22 · Next: ‘4’ on 6/15/23 for 6/8/23 · Latest: ‘4/A’ on 6/27/23 for 6/8/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Reporting Owners

Signatures

Explanation of Responses:

Sherman Steven – ‘4’ for 5/24/23 re: Ekso Bionics Holdings, Inc.

On: Friday, 5/26/23, at 6:45pm ET · For: 5/24/23 · As: Officer · Accession #: 1549084-23-35 · File #: 1-37854

Previous ‘4’: ‘4/A’ on 5/17/23 for 3/8/22 · Next: ‘4’ on 6/15/23 for 6/8/23 · Latest: ‘4/A’ on 6/27/23 for 6/8/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Reporting Owners

Signatures

Explanation of Responses:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents